PFE
Pfizer Inc.
Stock
$28.72+0.05 (+0.17%)Close Sep 28, 2026
Balance sheet
| Line | Q2 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $8.3B | $10.3B | $11.9B | $7.3B | $19.2B | $24.0B | $11.5B | $7.8B | $16.2B | $16.7B | $17.2B | $23.3B | $36.1B | $32.4B | $32.4B | $26.5B | $28.0B | $26.0B | $23.7B | $3.4B |
| Inventory | $9.9B | $10.7B | $10.9B | $10.2B | $9.0B | $9.1B | $8.0B | $7.1B | $7.5B | $7.6B | $6.8B | $7.5B | $5.7B | $6.2B | $6.1B | $6.6B | $8.3B | $12.4B | $4.4B | — |
| Current assets | $41.4B | $42.9B | $50.4B | $43.3B | $51.3B | $59.7B | $35.1B | $32.8B | $49.9B | $41.1B | $38.9B | $43.8B | $55.6B | $56.2B | $64.8B | $60.8B | $61.0B | $61.7B | $43.1B | — |
| Goodwill | $71.4B | $71.3B | $68.5B | $67.8B | $51.4B | $49.2B | $49.6B | $48.2B | $53.4B | $56.0B | $54.4B | $48.2B | $42.1B | $42.5B | $43.7B | $44.6B | $43.9B | $42.4B | $21.5B | — |
| Intangible assets | $47.1B | $53.7B | $55.4B | $64.9B | $43.4B | $25.1B | $28.3B | $33.9B | $35.2B | $48.7B | $52.6B | $40.4B | $35.2B | $39.4B | $45.1B | $51.2B | $57.6B | $68.0B | $17.7B | — |
| Total assets | $201.1B | $208.2B | $213.4B | $226.5B | $197.2B | $181.5B | $154.2B | $167.6B | $159.4B | $171.8B | $171.6B | $167.4B | $167.6B | $172.1B | $185.8B | $188.0B | $195.0B | $212.9B | $111.1B | — |
| Current liabilities | $32.6B | $37.0B | $43.0B | $47.8B | $42.1B | $42.7B | $25.9B | $37.3B | $31.9B | $30.4B | $31.1B | $29.4B | $21.6B | $23.4B | $29.2B | $28.9B | $28.6B | $37.2B | $27.0B | — |
| Long-term debt | $60.5B | $61.6B | $57.4B | $61.5B | $32.9B | $36.2B | $37.1B | $36.0B | $32.9B | $33.5B | $31.4B | $28.7B | $31.5B | $30.5B | $31.0B | $34.9B | $38.4B | $43.2B | $8.0B | — |
| Total liabilities | $115.6B | $121.4B | $124.9B | $137.2B | $101.3B | $104.0B | $90.8B | $104.1B | $95.7B | $100.1B | $111.8B | $102.4B | $95.9B | $95.5B | $104.1B | $105.4B | $106.7B | $122.5B | $53.4B | — |
| Shareholders' equity | $85.2B | $86.5B | $88.2B | $89.0B | $95.7B | $77.2B | $63.2B | $63.1B | $63.4B | $71.3B | $59.5B | $64.7B | $71.3B | $76.3B | $81.3B | $82.2B | $87.8B | $90.0B | $57.6B | $65.1B |
| Shares outstanding | 5.70B | 5.69B | 5.67B | 5.65B | 5.62B | 5.62B | 5.58B | 5.55B | 5.55B | 5.95B | 5.95B | 6.18B | 6.13B | 6.38B | 7.19B | 7.54B | 8.00B | 8.07B | — | — |
| Current ratio | 1.27 | 1.16 | 1.17 | 0.91 | 1.22 | 1.40 | 1.35 | 0.88 | 1.57 | 1.35 | 1.25 | 1.49 | 2.58 | 2.41 | 2.22 | 2.10 | 2.13 | 1.66 | 1.59 | — |